Document is current
Any future updates will be listed below
-
Authors
Cox, Ingrid A. https://orcid.org/0000-0001-5130-4088
de Graaff, Barbara
Ahmed, Hasnat
Campbell, Julie
Otahal, Petr
Corte, Tamera J.
Moodley, Yuben
Goh, Nicole
Hopkins, Peter
Macansh, Sacha
Walters, E. Haydn
Palmer, Andrew J.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (GNT1116371))
Boehringer Ingelheim
Roche
Galapagos Conservancy
University of Tasmania
- License Information
-
More Information
Article History
Received: 21 February 2022
Accepted: 7 October 2022
First Online: 27 October 2022
Declarations
:
: TC reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Roche, grants and personal fees from BMS, personal fees from Promedior, personal fees from Ad Alta, grants from Avalyn Pharma, grants from Biogen, outside the submitted work. All other authors declare that they have no financial/competing interests.
: All study procedures were approved by the University of Tasmania Human Research Ethics Committee (H0016914), Sydney Local Health District, Royal Prince Alfred Zone (Protocol Number X18-0192, Project Number HREC/18/RPAH/269 and SSA/18/RPAH/435), Alfred Health (Site Authorization Letter 45217) and the Hunter New England Local Health District (SSA/19/HNE/23).
: The authors affirm that signed informed consent was obtained from all individual participants included in this study.
: The authors affirm that individual participants provided informed consent for publication of their data.
